Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 2:16 PM
Ignite Modification Date:
2025-12-24 @ 2:16 PM
NCT ID:
NCT01431495
Eligibility Criteria:
Inclusion Criteria:
* Male or female,
* Old (e) over 20 years
* Patients hospitalized for acute coronary syndrome (Whatever the T and troponin)
* Patients with proven coronary candidates for treatment with clopidogrel (who received a loading dose of 600mg over 2 hours and treated with 75mg / d of clopidogrel for longer than 7 days)
Exclusion Criteria:
* Patients unwilling.
* Patient participating in another study.
* Patients with cardiogenic shock
* Patient on anti GpIIbIIIa or stopped less than 72 hours before the test aggregability
* Patients scheduled for surgery in less than 6 months.
* Patients candidates for coronary angioplasty
* Patients who underwent TAC + / - bare stent fewer than 30 days.
* Patients who underwent stenting with ATC active there is less than 12 months.
* ischemic stroke older than 6 weeks.
* History of hemorrhagic stroke (any time)
* Patients on warfarin or candidates
* Patients with a different anti ADP (ticlopidine, prasugrel)
* Patients with indication for clopidogrel-cons (side effects, bleeding ...)
* Thrombocytopenia \<100000/mm3
* anemia (Ht \<30%)
* Thrombocythaemia (Ht\> 52%)
* Patients seeking treatment for an elective forms of Clopidogrel.
* Pregnancy
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT01431495
Study Brief:
Protocol Section:
NCT01431495